# Design Therapeutics, Inc.: Form SC 13D/A, filed Dec 22, 2022

- Company: [Design Therapeutics, Inc.](/companies/dsgn.md) (CIK 1807120)
- Form: SC 13D/A
- Filed: 2022-12-22
- Accepted by EDGAR: Dec 22, 2022, 16:25 ET
- Period: not reported
- Accession: 0001193125-22-311061
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1807120/000119312522311061/d410293dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1807120/000119312522311061/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1807120/000119312522311061/d410293dsc13da.htm

Filed Dec 22, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-311061. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
